QQ客服 官方微博 反馈留言

	Insulin Resistance in Polycystic Ovary Syndrome Improved by Chinese Medicine Dingkun Pill (定坤丹): A Randomized Controlled Clinical Trial
	Deng Yan; Xue Wei; Wang Yanfang; Liu Xiaohui; Zhu Shiyang; Ma Xiao; Zuo Hongling; Jiang Jianfa; Zheng Tingping; Sun Aijun
	2019
卷号	25期号:4页码:246-251
关键词	Diane-35 Dingkun Pill Chinese medicine polycystic ovary syndrome oral glucose tolerance tests insulin resistance
DOI	10.1007/s11655-018-2947-1
URL标识	查看原文
收录类别	SCIE ; PubMed ; CSCD
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6341099
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Deng Yan,Xue Wei,Wang Yanfang,等. Insulin Resistance in Polycystic Ovary Syndrome Improved by Chinese Medicine Dingkun Pill (定坤丹): A Randomized Controlled Clinical Trial[J],2019,25(4):246-251.
APA	Deng Yan.,Xue Wei.,Wang Yanfang.,Liu Xiaohui.,Zhu Shiyang.,...&Sun Aijun.(2019).Insulin Resistance in Polycystic Ovary Syndrome Improved by Chinese Medicine Dingkun Pill (定坤丹): A Randomized Controlled Clinical Trial.,25(4),246-251.
MLA	Deng Yan,et al."Insulin Resistance in Polycystic Ovary Syndrome Improved by Chinese Medicine Dingkun Pill (定坤丹): A Randomized Controlled Clinical Trial".25.4(2019):246-251.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。